Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Prognostic Value of Troponin T for Long-term Outcome After Cardiac Surgery

This study has been completed.
Information provided by (Responsible Party):
University Hospital, Basel, Switzerland Identifier:
First received: May 2, 2007
Last updated: March 9, 2015
Last verified: March 2015
This survey has two aims. First, we would like to be informed about the health condition of our patients two years following heart surgery at University Hospital, Basel. Second, we are interested in determining whether a patient's long-term outcome can be predicted by the analysis of blood samples taken shortly after heart surgery.Troponin T, the blood parameter that we are interested in, is routinely assessed in the Intensive Care Unit. The purpose of this survey is to determine whether or not it is also possible to infer the long-term outcome from this blood parameter.

Heart; Dysfunction Postoperative, Cardiac Surgery
Adverse Anesthesia Outcome

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Prognostic Value of Troponin T for Long-term Outcome After Cardiac Surgery

Resource links provided by NLM:

Further study details as provided by University Hospital, Basel, Switzerland:

Primary Outcome Measures:
  • Death and/or major adverse cardiac events [ Time Frame: 12 months after cardiac surgery ] [ Designated as safety issue: Yes ]

Enrollment: 3000
Study Start Date: January 2007
Study Completion Date: March 2013
Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)
  Show Detailed Description


Ages Eligible for Study:   16 Years and older   (Child, Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
adults patients undergoing on-pump cardiac surgery at University Hospital Basel

Inclusion Criteria:

  • On-pump cardiac surgery at University Hospital of Basel

Exclusion Criteria:

  • Off-pump cardiac surgery
  • Procedures requiring hypothermic cardiocirculatory arrest
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00468598

University Hospital
Basel, Basel-Stadt, Switzerland, 4052
Sponsors and Collaborators
University Hospital, Basel, Switzerland
Principal Investigator: Miodrag Filipovic, MD Anesthesiology department, University Hospital of Basel
  More Information

Responsible Party: University Hospital, Basel, Switzerland Identifier: NCT00468598     History of Changes
Other Study ID Numbers: 06/07 
Study First Received: May 2, 2007
Last Updated: March 9, 2015
Health Authority: Switzerland: Ethikkommission

Keywords provided by University Hospital, Basel, Switzerland:
long-term outcome
on-pump cardiac surgery processed this record on October 27, 2016